Assignee
MULTIVIR INC
US·2 granted patents·5 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
7 records- 0168US2026049111A1Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancerMULTIVIR INC·Filed 2025·Application pending·0 cites
- 0259US12454561B2Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancerMULTIVIR INC·Filed 2019·Granted Oct 28, 2025·0 cites·23 claims
- 0359US10883993B2P53 biomarkersMULTIVIR INC·Filed 2017·Granted Jan 5, 2021·0 cites·12 claims
- 0457US2021090124A1P53 biomarkersMULTIVIR INC·Filed 2020·Application pending·0 cites
- 0549US2024042061A1Methods and compositions comprising tumor suppressor gene therapy for the inhibition of pathogensMULTIVIR INC·Filed 2021·Application pending·0 cites
- 0638US2020009203A1Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseasesMULTIVIR INC·Filed 2017·Application pending·0 cites
- 0736US2019038713A1Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancerMULTIVIR INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →